165 related articles for article (PubMed ID: 28597026)
21. Transformation of cutaneous gamma/delta T-cell lymphoma following 15 years of indolent behavior.
Hosler GA; Liégeois N; Anhalt GJ; Moresi JM
J Cutan Pathol; 2008 Nov; 35(11):1063-7. PubMed ID: 18544066
[TBL] [Abstract][Full Text] [Related]
22. Chemotherapy with etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone in patients with refractory cutaneous T-cell lymphoma.
Akpek G; Koh HK; Bogen S; O'Hara C; Foss FM
Cancer; 1999 Oct; 86(7):1368-76. PubMed ID: 10506727
[TBL] [Abstract][Full Text] [Related]
23. Rare provisional entity: primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma in a young woman.
Csomor J; Bognár A; Benedek S; Sinkó J; Fekete S; Krenács L; Matolcsy A; Reiniger L
J Clin Pathol; 2008 Jun; 61(6):770-2. PubMed ID: 18505891
[TBL] [Abstract][Full Text] [Related]
24. Cutaneous involvement in systemic anaplastic large cell lymphoma.
Kwok C; Salmo E
J Dtsch Dermatol Ges; 2015 Jul; 13(7):693-5. PubMed ID: 26031654
[No Abstract] [Full Text] [Related]
25. Primary cutaneous aggressive epidermotropic CD8 + T-cell lymphoma on upper eyelid.
Lee J; Yang YJ; Kim JI; Park JH; Kim WS
Indian J Ophthalmol; 2015 Jan; 63(1):81-2. PubMed ID: 25686076
[No Abstract] [Full Text] [Related]
26. Primary Cutaneous CD8+ T-cell Lymphoma, an Indolent and Locally Aggressive Form Mimicking Paronychia.
Beggs SM; Friedman BJ; Kornreich D; Okon L; Alpdogan O; Shi W; Sahu J
Am J Dermatopathol; 2018 Apr; 40(4):e52-e56. PubMed ID: 28984695
[TBL] [Abstract][Full Text] [Related]
27. Primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma in a human T-cell leukaemia virus type-1 carrier.
Ohmatsu H; Sugaya M; Fujita H; Miyagaki T; Kadono T; Maeda D; Takazawa Y; Fukayama M; Tamaki K; Sato S
Acta Derm Venereol; 2010 May; 90(3):324-5. PubMed ID: 20526566
[No Abstract] [Full Text] [Related]
28. Four versus six courses of a dose-escalated cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus etoposide (megaCHOEP) and autologous stem cell transplantation: early dose intensity is crucial in treating younger patients with poor prognosis aggressive lymphoma.
Schmitz N; Kloess M; Reiser M; Berdel WE; Metzner B; Dorken B; Kneba M; Trumper L; Loeffler M; Pfreundschuh M; Glass B;
Cancer; 2006 Jan; 106(1):136-45. PubMed ID: 16331635
[TBL] [Abstract][Full Text] [Related]
29. Primary Cutaneous Gamma-Delta (γ/δ) T-cell Lymphoma: An Unusual Case With Very Subtle Histopathological Findings.
Ramani NS; Curry JL; Merrill ED; Aung PP; Prieto V; Tetzlaff MT; Duvic M; Miranda RN; Torres-Cabala C
Am J Dermatopathol; 2016 Oct; 38(10):e147-9. PubMed ID: 27533072
[TBL] [Abstract][Full Text] [Related]
30. Primary cutaneous CD8+ aggressive epidermotropic T-cell lymphoma mimicking pyoderma gangrenosum.
Flora A; Gibson M; Toon C; Rawson R; Lowe P
Indian J Dermatol Venereol Leprol; 2021; 88(1):90-92. PubMed ID: 34951938
[No Abstract] [Full Text] [Related]
31. Primary cutaneous CD8+ cytotoxic T-cell lymphoma involving the epidermis and subcutis in a young child.
Wang L; Gao T; Wang G
J Cutan Pathol; 2015 Apr; 42(4):271-5. PubMed ID: 25458991
[TBL] [Abstract][Full Text] [Related]
32. Primary cutaneous aggressive epidermotropic CD8+ T cell lymphoma: a diagnostic and therapeutic challenge.
Nofal A; Abdel-Mawla MY; Assaf M; Salah E; Abd-Elazim H
Int J Dermatol; 2014 Jan; 53(1):76-81. PubMed ID: 23786415
[No Abstract] [Full Text] [Related]
33. A Case of Primary Cutaneous Aggressive Epidermotropic CD8+ Cytotoxic T-cell Lymphoma Misdiagnosed as Febrile Ulceronecrotic Mucha-Habermann Disease.
Sheng N; Li Z; Su W; Liu W; Zong W; Wang B; Feng S
Acta Derm Venereol; 2016 Jan; 96(1):136-7. PubMed ID: 26039505
[No Abstract] [Full Text] [Related]
34. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma: transformation from indolent to aggressive phase in association with CCR7-positive conversion.
Kasuya A; Hirakawa S; Tokura Y
Dermatol Online J; 2012 Oct; 18(10):5. PubMed ID: 23122012
[TBL] [Abstract][Full Text] [Related]
35. Pyoderma gangrenosum in a patient with primary cutaneous peripheral T-cell lymphoma, not otherwise specified.
Patsatsi A; Koletsa T; Sotiriadis D; Kartsios C; Papaconstantinou A; Kostopoulos I
Eur J Dermatol; 2012; 22(6):792-3. PubMed ID: 23228951
[No Abstract] [Full Text] [Related]
36. Successful treatment for recurrence of primary cutaneous anaplastic large-cell lymphoma in elderly patient with etoposide, mitoxantrone, cyclophosphamide, vincristine, prednisolone and bleomycin (VNCOP-B) therapy.
Isogai R; Fukao M; Kawada A
J Dermatol; 2007 Aug; 34(8):556-60. PubMed ID: 17683387
[TBL] [Abstract][Full Text] [Related]
37. Lymphomatoid papulosis type D or an aggressive epidermotropic CD8(+) cytotoxic T-cell lymphoma?
Andersen RM; Larsen MS; Poulsen TS; Lauritzen AF; Skov L
Acta Derm Venereol; 2014 Jul; 94(4):474-5. PubMed ID: 24217891
[No Abstract] [Full Text] [Related]
38. Aggressive epidermotropic cutaneous CD8+ (Berti's) lymphoma.
Webber NK; Harwood C; Goldsmith P; Cerio R; Wells P; Kazmi M; Russell-Jones MR; Morris S; Robson A
Clin Exp Dermatol; 2010 Jun; 35(4):e210-2. PubMed ID: 20518920
[No Abstract] [Full Text] [Related]
39. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma: proposed diagnostic criteria and therapeutic evaluation.
Nofal A; Abdel-Mawla MY; Assaf M; Salah E
J Am Acad Dermatol; 2012 Oct; 67(4):748-59. PubMed ID: 22226429
[TBL] [Abstract][Full Text] [Related]
40. Fatal Case of Primary Cutaneous Aggressive T-Cell Lymphoma Switching From a CD4+ to a CD8+ Phenotype: Progressive Disease With Bexarotene and Romidepsin Treatment.
Johnson WT; Leeman-Neill RJ; Patel P; Ho J; Grandinetti LM; Jedrych J; Craig FE
Am J Dermatopathol; 2016 Nov; 38(11):832-837. PubMed ID: 27322928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
